

Satellite Symposia & Meet the Expert Programme
Please find the programme of our industry partners below.
Kindly note that not all symposia will be available for virtual attendance or as webcasts after the conference.

Wednesday, 12 March | 11:30-12:30
Navigating complex treatment decisions for gBRCAm HER2-negative eBC

Thursday, 13 March | 08:00-08:45
Current and Future Treatment Strategies for Patients With ER+/HER2- Early Breast Cancer

Thursday, 13 March | 11:30-12:30
Shaping the future of treatment decision making using Multigene Assays (MGA): an expert round table discussion

Thursday, 13 March | 17:45-18:45
Elevating Care: Identifying Patients with High-Risk HR+ HER2- EBC Who May Benefit From Treatment Intensification?

Friday 14 March | 08:00-08:45
Illuminating a Better Path Forward for HR+, HER2- MBC: Bridging the Science and Art of Medicine in Clinical Decision-Making (CME/EBAC/AAPA/NCPD/IPCE-accredited)

Friday 14 March | 11:30-12:30
Completing the Picture: ADCs in Early HER2+ Breast Cancer Care

Friday 14 March |17:45-18:45
Redefining Risk of Recurrence: Latest advances with CDK4/6 inhibitors in HR+/HER2− early breast cancer
